BRISBANE, Calif.--(BUSINESS WIRE)--XDx, Inc., a molecular diagnostics company focused on noninvasive gene expression tests for the monitoring of immune-mediated conditions, announced today that it has ...
Oxford Finance LLC (“Oxford”), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced a $15 million round of debt financing for XDx, Inc ...
BRISBANE, Calif.--(BUSINESS WIRE)--XDx, Inc., a molecular diagnostics company focused on noninvasive gene expression tests for the monitoring of immune-mediated conditions, today announced the ...
When XDx yesterday filed to raise up to $86.3 million in an IPO, the Brisbane, Calif., company joined just a handful of similar molecular-diagnostic companies to test the public markets. XDx ...
MISSISSAUGA, ONTARIO and BRISBANE, CALIFORNIA--(Marketwired - Jun 20, 2013) - CML HealthCare Inc. (CLC.TO) (the "Company" or "CML HealthCare"), a leading provider of medical diagnostic services in ...
BRISBANE, Calif.--(BUSINESS WIRE)--XDx, Inc., a molecular diagnostics company that discovers, develops and commercializes high value, non-invasive tests to monitor immune status in transplant ...
PARIS & BRISBANE, Calif.--(BUSINESS WIRE)--Regulatory News: Diaxonhit (Paris:ALEHT), the leading French provider of specialty diagnostic solutions, and XDx, Inc., a U.S. molecular diagnostics company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results